Treatment with anti‐IL‐1β antibody did not affect the number of TAMs (Figure 6D), but reduced the quantity of MDSCs (Figure 6E) and increased the number of tumor‐infiltrating CD8+ T cells (Figure 6F). This evidence concerns the gene IL1B and neoplasm.